Parkinson's Disease Therapeutics. Emphasis on Nanotechnological Advances

Table of Contents

1. Introduction: Parkinson's Disease Pathology and Therapeutics2. Biomaterials: A Boon or a Bane in the Treatment of Parkinson's Disease3. Blood Brain Barrier4. Natural Compounds in the Treatment of Parkinson's Disease5. Curcumin: A Promising Therapeutic in Parkinson's Disease Treatment6. Redox Nanoparticles: The Corner Stones in the Development of Parkinson's Disease Therapeutics7. Liposomal Maneuvers against Parkinson's Disease8. Nasal Delivery Nanoparticles: An Insight into Novel Parkinson's Disease Therapeutics9. a-Synuclein Targeted Nanoparticles10. Pros and Cons of Parkinson's Disease Therapeutics

Authors

Magisetty Obulesu Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. Magisetty Obulesu is a research associate at the Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. He has 20 years of research and teaching experience. He is also an editorial board of nanotechnology journals including SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science. His research areas include food science, pathology of neurodegenerative diseases such as Alzheimer's disease, designing polymer-based biomaterials such as hydrogels, and development of metal chelators to overcome metal induced toxicity. He has researched Alzheimer's disease and developed an aluminium-induced neurotoxicity rabbit model. Mr. Obulesu's present research focuses on development of redox-active injectable hydrogels of polyion complex. He has written three books and edited two more; he is also the first and corresponding author for majority of his articles.